Minaris Advanced Therapies
Haren Brahmbhatt is a seasoned professional in quality assurance and business analysis, currently serving as a Business Analyst in Quality Assurance at Minaris Advanced Therapies since May 2025. Prior experience includes similar roles at Advanced Therapies, LLC, and 3M, where expertise was demonstrated in supporting STARLIMS applications and providing testing support for software products. Haren began a career in validation and business analysis at Baxter International Inc. and Validation Technology Services Inc., focusing on global implementations and data analysis. Educational credentials include a Master of Business Administration in Organizational Leadership from The University of Findlay and a Bachelor of Business Administration from Sardar Patel University.
This person is not in any teams
This person is not in any offices
Minaris Advanced Therapies
1 followers
Minaris Advanced Therapies is a global contract development and manufacturing organization (CDMO) and contract testing provider focused exclusively on cell and gene therapies. Minaris Advanced Therapies is headquartered in Philadelphia, Pennsylvania, and has more than 730,000 square feet of infrastructure across the United States, Europe and Asia. We have manufactured and released over 7,500 GMP batches and our global network supports therapy developers through early-stage development, clinical trials and commercial manufacturing. By combining scientific expertise with best-in-class manufacturing and testing services, we help bring safe, effective therapies to patients faster and more efficiently. With more than 20 years’ experience in the field of regenerative medicine, we are trusted partner ensuring scalability, delivering high quality results, and achieving cost effective manufacturing. Our state-of-the-art facilities in the United States, Europe, and Asia, as well as our committed employees, enable us to supply patients worldwide with lifechanging therapies. Minaris Advanced Therapies is wholly owned by Altaris, LLC.